Adamis Pharmaceuticals Corp

NASDAQ:ADMP   3:59:56 PM EDT
0.43
+0.02 (+5.29%)
Products

Adamis Pharmaceuticals Receives A Complete Response Letter From The FDA Regarding Zimhi

Published: 11/16/2020 11:58 GMT
Adamis Pharmaceuticals Corp (ADMP) - Adamis Pharmaceuticals Receives a Complete Response Letter From the FDA Regarding Zimhi.
Adamis Pharmaceuticals - Crl Stated FDA Determined It Cannot Approve NDA in Its Present Form and Provided Recommendations Needed for Resubmission.
Adamis Pharmaceuticals Corp - Questions Raised by FDA Related Generally to New Chemistry, Manufacturing and Controls (cmc) Issues.
Adamis Pharmaceuticals Corp - Company's Plan is to Provide FDA With Additional Analysis and Information in Order to Attempt to Satisfy Crl Items.
Adamis Pharmaceuticals Corp - Will Request a Type a Meeting Or Consider Other Options to Resolve Issues.